SCHEMBL984894

SCHEMBL984894

O=C(CO)N[C@H]1CC[C@H](NC(=O)c2c[nH]c3c(-c4ccc(F)cc4OCC4CC4)ncnc23)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
HPGD P15428 1/20 0.35
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
CRHR1 P34998 3/20 0.34
CNR1 P21554 3/20 0.34
SCN8A Q9UQD0 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.34
CRHR2 Q13324 2/20 0.34
CCNT1 O60563 1/20 0.34
CDK9 P50750 1/20 0.34
CNR2 P34972 3/20 0.33
TDO2 P48775 1/20 0.33
LMNA P02545 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SYK P43405 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL985885 1.00 GRIN1 (0.36) GRIN1GRIN2BALDH1A1KMT2AHPGD
SCHEMBL983050 0.94 BRD4 (0.37) GRIN1GRIN2BALDH1A1KMT2AHPGD
SCHEMBL985733 0.91 BTK (0.40) GRIN1GRIN2BALDH1A1KMT2AHPGD
SCHEMBL985542 0.91 BTK (0.40) GRIN1GRIN2BALDH1A1KMT2AHPGD
SCHEMBL981859 0.91 SMYD3 (0.41) ALDH1A1KMT2AHPGDKDM5AKDM4C
SCHEMBL986391 0.91 CDK9 (0.41) GRIN1GRIN2BALDH1A1KMT2AHPGD
SCHEMBL984182 0.91 SMYD3 (0.41) ALDH1A1KMT2AHPGDKDM5AKDM4C
SCHEMBL985350 0.91 CDK9 (0.41) GRIN1GRIN2BALDH1A1KMT2AHPGD
SCHEMBL983586 0.91 BTK (0.35) GRIN1GRIN2BALDH1A1KMT2AHPGD
SCHEMBL984646 0.90 ACKR3 (0.41) ALDH1A1KMT2AKDM5AKDM4CSCN8A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US claimed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A GRIN1 2493/4885GRIN2B 2516/4885ALDH1A1 924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.